Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1999 1
2005 1
2006 2
2007 1
2010 1
2015 1
2017 2
2018 4
2019 3
2020 8
2021 5
2022 1
2024 3
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

26 results

Results by year

Filters applied: . Clear all
Page 1
Expression of concern: "Different T cell related immunological profiles in COVID-19 patients compared to healthy controls" [Int. Immunopharmacol. 97 (2021) 107828].
Khesht AMS, Karpisheh V, Saeed BQ, Zekiy AO, Yapanto LM, Afjadi MN, Aksoun M, Esfahani MN, Aghakhani F, Movahed M, Joshi N, Abbaszadeh-Goudarzi K, Hallaj S, Ahmadi M, Dolati S, Mahmoodpoor A, Hashemi V, Jadidi-Niaragh F. Khesht AMS, et al. Among authors: hashemi v. Int Immunopharmacol. 2024 Sep 10;138:112594. doi: 10.1016/j.intimp.2024.112594. Epub 2024 Jul 14. Int Immunopharmacol. 2024. PMID: 39075740 Free PMC article. No abstract available.
Retraction notice to "Simultaneous silencing of the A2aR and PD-1 immune checkpoints by siRNA-loaded nanoparticles enhances the immunotherapeutic potential of dendritic cell vaccine in tumor experimental models" [Life Sci. 288 (2022) 120166].
Kiani FK, Izadi S, Dezfouli EA, Ebrahimi F, Mohammadi M, Chalajour H, Bulus MM, Esfahani MN, Karpisheh V, Khesht AMS, Abbaszadeh-Goudarzi K, Soleimani A, Navashenaq JG, Ahmadi M, Hassannia H, Hojjat-Farsangi M, Farid SS, Hashemi V, Jadidi-Niaragh F. Kiani FK, et al. Among authors: hashemi v. Life Sci. 2024 Aug 1;350:122775. doi: 10.1016/j.lfs.2024.122775. Epub 2024 Jun 8. Life Sci. 2024. PMID: 38851943 No abstract available.
Retraction notice to "Silencing of p68 and STAT3 synergistically diminishes cancer progression" [Life Sci. 249 (2020) 117499].
Hashemi V, Ahmadi A, Malakotikhah F, Chaleshtari MG, Moornani MB, Masjedi A, Sojoodi M, Atyabi F, Nikkhoo A, Rostami N, Baradaran B, Azizi G, Yousefi B, Ghalamfarsa G, Jadidi-Niaragh F. Hashemi V, et al. Life Sci. 2024 Aug 1;350:122772. doi: 10.1016/j.lfs.2024.122772. Epub 2024 Jun 6. Life Sci. 2024. PMID: 38845264 No abstract available.
Simultaneous silencing of the A2aR and PD-1 immune checkpoints by siRNA-loaded nanoparticles enhances the immunotherapeutic potential of dendritic cell vaccine in tumor experimental models.
Karoon Kiani F, Izadi S, Ansari Dezfouli E, Ebrahimi F, Mohammadi M, Chalajour H, Mortazavi Bulus M, Nasr Esfahani M, Karpisheh V, Mahmoud Salehi Khesht A, Abbaszadeh-Goudarzi K, Soleimani A, Gholizadeh Navashenaq J, Ahmadi M, Hassannia H, Hojjat-Farsangi M, Shahmohammadi Farid S, Hashemi V, Jadidi-Niaragh F. Karoon Kiani F, et al. Among authors: hashemi v. Life Sci. 2022 Jan 1;288:120166. doi: 10.1016/j.lfs.2021.120166. Epub 2021 Nov 20. Life Sci. 2022. Retraction in: Life Sci. 2024 Aug 1;350:122775. doi: 10.1016/j.lfs.2024.122775 PMID: 34813798 Retracted.
Different T cell related immunological profiles in COVID-19 patients compared to healthy controls.
Mahmoud Salehi Khesht A, Karpisheh V, Qubais Saeed B, Olegovna Zekiy A, Yapanto LM, Nabi Afjadi M, Aksoun M, Nasr Esfahani M, Aghakhani F, Movahed M, Joshi N, Abbaszadeh-Goudarzi K, Hallaj S, Ahmadi M, Dolati S, Mahmoodpoor A, Hashemi V, Jadidi-Niaragh F. Mahmoud Salehi Khesht A, et al. Among authors: hashemi v. Int Immunopharmacol. 2021 Aug;97:107828. doi: 10.1016/j.intimp.2021.107828. Epub 2021 May 28. Int Immunopharmacol. 2021. PMID: 34091116 Free PMC article.
Corrigendum to "IL-21 and IL-21-producing T cells are involved in multiple sclerosis severity and progression" [Immunol. Lett. 216 (2019) 12-20].
Gharibi T, Hosseini A, Marofi F, Oraei M, Jahandideh S, Abdollahpour-Alitappeh M, Hashemi V, Motallebnezhad M, Babaloo Z, Baradaran B. Gharibi T, et al. Among authors: hashemi v. Immunol Lett. 2021 Apr;232:67. doi: 10.1016/j.imlet.2020.12.013. Epub 2021 Jan 16. Immunol Lett. 2021. PMID: 33461760 No abstract available.
Innate and adaptive immune responses against coronavirus.
Hosseini A, Hashemi V, Shomali N, Asghari F, Gharibi T, Akbari M, Gholizadeh S, Jafari A. Hosseini A, et al. Among authors: hashemi v. Biomed Pharmacother. 2020 Dec;132:110859. doi: 10.1016/j.biopha.2020.110859. Epub 2020 Oct 22. Biomed Pharmacother. 2020. PMID: 33120236 Free PMC article. Review.
Angiotensin-converting enzyme as a new immunologic target for the new SARS-CoV-2.
Hallaj S, Ghorbani A, Mousavi-Aghdas SA, Mirza-Aghazadeh-Attari M, Sevbitov A, Hashemi V, Hallaj T, Jadidi-Niaragh F. Hallaj S, et al. Among authors: hashemi v. Immunol Cell Biol. 2021 Feb;99(2):192-205. doi: 10.1111/imcb.12396. Epub 2020 Oct 7. Immunol Cell Biol. 2021. PMID: 32864784 Review.
26 results